Amniotic Membrane Market Size, Share & Trends Analysis Report and Segment Forecast, 2025| Grand View Research, Inc “The global amniotic membrane market size was valued at USD 2.26 billion in 2017 and is estimated to register a CAGR of 12.6% during the forecast period.” The global Amniotic Membrane Market size is expected to reach USD 5.81 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a CAGR of 12.6% during the forecast period. Rise in trauma, burn cases and resulting surgeries along with increasing awareness regarding the benefits of these products are boosting the market growth. Rising number of cosmetic surgeries performed is also anticipated to drive the market during the forecast period. Amniotic membrane is also used in the treatment of a large number of ocular surface diseases as it protects surfaces from microbial colonization preventing the risk of infections. Moreover, presence of growth factors including basic Fibroblast Growth Factor (bFGF), Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Nerve Growth Factor (NGF), and Keratinocyte Growth Factor (KGF) in amniotic membranes promote wound healing, accelerating its adoption globally. Thus, its benefits, such as anti-inflammatory properties, reduced fibrosis and scarring at the site of surgery, pain reduction, and wound healing properties, are also fueling the demand. These products are thus most commonly used in surgeries, treatment of venous, pressure, and diabetic foot ulcers, ophthalmology, and in the management of chronic wounds. Follow Us: The American Association of Tissue Banks is a non-profit organization that regulates tissue donation in U.S. Presence of such tissue banks ensures zero disease transmission, which, in turn, propels market growth. Furthermore, a number of institutes are trying to introduce novel areas of applications for these products by focusing on the research activities in stem cell and regenerative medicines. This factor is also likely to support market expansion. The use of cryopreserved amniotic membrane is largely seen in hospitals, Ambulatory Surgical Centers (ASCs), and specialty clinics. Lyophylization of the tissue post donation preserves the histological and biological activity of the tissue facilitating faster wound recovery. To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/amniotic-membrane-market Further key findings from the study suggest: Cryopreserved is expected to be the dominant segment in future as it’s highly effective and ensures preservation of histological and biological properties Surgical wounds segment is projected to witness high growth due to increasing usage of these products for surgical applications Specialty clinics are anticipated to register the highest CAGR during the forecast period due to increasing number of cosmetic and reconstructive surgeries being performed North America is a leading regional market owing to presence of a large number of key companies and high incidence of chronic and infectious diseases The Asia Pacific region is expected to record the highest CAGR during the forecast period due to growing population and rising incidence of chronic diseases and burn injuries Major companies in the amniotic membrane market include Alliqua BioMedical Inc.; Amnio Technology, Applied Biologics LLC; Human Regenerative Technologies DermaSciences; Katena Products, MiMedx Group Inc.; and Skye Biologics, Inc. Grand View Research has segmented the global amniotic membrane market on the basis of enzyme, application, end use, and region: Amniotic Membrane Enzyme Outlook (Revenue, USD Million, 2014 - 2025) Follow Us: Cryopreserved Amniotic Membrane Dehydrated Amniotic Membrane Amniotic Membrane Application Outlook (Revenue, USD Million, 2014 - 2025) Surgical Wounds Ophthalmology Others Amniotic Membrane End Use Outlook (Revenue, USD Million, 2014 - 2025) Hospitals Ambulatory Surgical Centers (ASCs) Specialty Clinics Research and Academic Institutes Amniotic Membrane Regional Outlook (Revenue, USD Million, 2014 - 2025) North America o U.S. o Canada Europe o U.K. o Germany Asia Pacific Follow Us: o Japan o China o India Latin America o Brazil o Mexico MEA Follow Us: o South Africa o Saudi Arabia Table of Content of Amniotic Membrane Market Chapter 1 Executive Summary Chapter 2 Research Methodology 2.1 Country-wise Market: Base Estimates 2.2 Global Market: CAGR Calculation 2.3 Region-based Segment Share Calculation 2.4 Research Scope & Assumptions 2.5 List of Data Sources 2.5.1 Data for primary interviews, by sources 2.5.2 Data for primary interviews, by region 2.6 Market Snapshot Chapter 3 Amniotic Membrane Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.2 Market Driver Analysis 3.2.1 Rising research on stem cell biology and regenerative medicine 3.2.2 Increasing awareness towards benefits offered by amniotic membrane 3.2.3 Rise in the number of accident and trauma cases 3.3 Market Restraint Analysis 3.3.1 Lack of skilled professionals 3.3.2 Lack of standardized guidelines 3.4 Key Opportunities Prioritized 3.4.1 Key opportunities prioritized, by product 3.4.2 Key opportunities prioritized, by application 3.4.3 Key opportunities prioritized, by end use 3.5 Amnitoic Membrane Market - SWOT Analysis, by Factor (Political & Legal, Economic and Technological) 3.6 Industry Analysis - Porter’s 3.7 Amnitoic Membrane Market: Company Market Position Analysis, 2017 Chapter 4 Amnitoic Membrane Market: Enzyme Estimates & Trend Analysis 4.1 Amnitoic Membrane Market: Product Movement Analysis Follow Us: 4.2 Cryopreserved Amniotic Membrane 4.2.1 Cryopreserved amniotic membrane market, 2014 - 2025 (USD Million) 4.3 Dehydrated Amniotic Membrane 4.3.1 Dehydrated amniotic membrane market, 2014 - 2025 (USD Million) Chapter 5 Amnitoic Membrane Market: Application Estimates & Trend Analysis 5.1 Amnitoic Membrane Market: Application Movement Analysis 5.2 Surgical Wounds 5.2.1 Surgical wounds market, 2014 - 2025 (USD Million) 5.3 Ophthalmology 5.3.1 Ophthalmology market, 2014 - 2025 (USD Million) 5.4 Others 5.4.1 Others market, 2014 - 2025 (USD Million) Chapter 6 Amnitoic Membrane Market: End Use Estimates & Trend Analysis 6.1 Amnitoic Membrane Market: End Use Movement Analysis 6.2 Hospitals 6.2.1 Hospitals market, 2014 - 2025 (USD Million) 6.3 Ambulatory Surgical Clinics 6.3.1 Ambulatory surgical clinics market, 2014 - 2025 (USD Million) 6.4 Specialty Clinics 6.4.1 Specialty clinics market, 2014 - 2025 (USD Million) 6.5 Research and Academic Institutes 6.5.1 Research and academic institutes market, 2014 - 2025 (USD Million) Chapter 7 Amnitoic Membrane Market: Regional Estimates & Trend Analysis, by Product, Application, and End Use 7.1 Amniotic Membrane Market Share, by Region, 2017 & 2025 7.2 North America 7.2.1 Market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.2.2 Market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.2.3 Market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.2.4 U.S. 7.2.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) Follow Us: 7.2.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.2.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.2.5 Canada 7.2.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.2.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.2.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.3 Europe 7.3.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.3.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.3.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.3.4 U.K. 7.3.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.3.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.3.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.3.5 Germany 7.3.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.3.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.3.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.4 Asia Pacific 7.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.4.4 Japan 7.4.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.4.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.4.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.4.5 China 7.4.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.4.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.4.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.4.6 India Follow Us: 7.4.6.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.4.6.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.4.6.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.5 Latin America 7.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.5.4 Brazil 7.5.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.5.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.5.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.5.5 Mexico 7.5.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.5.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.5.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.6 Middle East & Africa (MEA) 7.6.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.6.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.6.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.6.4 South Africa 7.6.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.6.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.6.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) 7.6.5 Saudi Arabia 7.6.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million) 7.6.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million) 7.6.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million) Chapter 8 Competitive Landscape 8.1 Company Profiles 8.1.1 Alliqua BioMedical Inc. 8.1.1.1 Company overview Follow Us: 8.1.1.2 Product benchmarking 8.1.1.3 Financial Performance 8.1.1.4 Strategic Initiatives 8.1.2 Amnio Technology, LLC 8.1.2.1 Company overview 8.1.2.2 Financial performance 8.1.2.3 Product benchmarking 8.1.2.4 Strategic Initiatives 8.1.3 Applied Biologics LLC 8.1.3.1 Company overview 8.1.3.2 Financial performance 8.1.3.3 Product benchmarking 8.1.3.4 Strategic Initiatives 8.1.4 Human Regenerative Technologies, LLC 8.1.4.1 Company overview 8.1.4.2 Financial performance 8.1.4.3 Product benchmarking 8.1.4.4 Strategic initiatives 8.1.5 DermaSciences. 8.1.5.1 Company overview 8.1.5.2 Financial performance 8.1.5.3 Product benchmarking 8.1.5.4 Strategic Initiatives 8.1.6 Katena Products, Inc. 8.1.6.1 Company overview 8.1.6.2 Financial performance 8.1.6.3 Product benchmarking 8.1.6.4 Strategic initiatives 8.1.7 MiMedx Group Inc. 8.1.7.1 Company overview 8.1.7.2 Financial performance Follow Us: 8.1.7.3 Product benchmarking 8.1.7.4 Strategic initiatives 8.1.8 Skye Biologics, Inc. 8.1.8.1 Company overview 8.1.8.2 Financial performance 8.1.8.3 Product benchmarking 8.1.8.4 Strategic initiatives 8.1.9 Amniox Medical Inc. 8.1.9.1 Company overview 8.1.9.2 Financial performance 8.1.9.3 Product benchmarking 8.1.9.4 Strategic initiatives 8.1.10 Integra LifeSciences 8.1.10.1 Company overview 8.1.10.2 Financial performance 8.1.10.3 Product benchmarking 8.1.10.4 Strategic initiatives Follow Us: About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ Follow Us:
The global amniotic membrane market size is expected to reach USD 5.81 billion by 2025
© Copyright 2024 Paperzz